MARISSA SAENGSAMRAN: Open Payments
NPI 1609931963 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 74 payments from 20 companies in 2025. Trend: 2023 $1,220 · 2024 $1,183 · 2025 $1,633
Food & beverage: $1,533Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $254 |
| PFIZER INC. | 12 | $224 |
| Arcutis Biotherapeutics, Inc. | 20 | $205 |
| GENZYME CORPORATION | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Galderma Laboratories, L.P. | 3 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $90 |
| Almirall LLC | 3 | $73 |
| Organon LLC | 5 | $73 |
| ABBVIE INC. | 3 | $71 |
Products named: TREMFYA, DUPIXENT, Zoryve, CIBINQO, LITFULO, SKYRIZI, NEMLUVIO, Rhapsido.
Industry payments across MO — which companies pay providers there.
